{"name":"Estradiol valerate","slug":"estradiol_valerate","kind":"substance","abbreviations":["EV"],"systematic":null,"aliases":["Estradiol 17-valerate","Delestrogen","Climaval","Oestradiol valerate","Deladumone","β-Estradiol 17-valerate","17-pentanoyl-estra-1,3,5(10)-triene-3,17β-diol","Estra-1,3,5(10)-triene-3,17-diol(17β)-, 17-pentanoate","Femtab","Progynon-depot-10"],"brands":[],"scraped":true,"has_structure":true,"cid":13791,"classes":[{"name":"estrogen","href":"/class/estrogen"},{"name":"hormone","href":"/class/hormone"},{"name":"steroid","href":"/class/steroid"}],"families":[{"name":"phenol","href":"/substituted/phenol"}],"physical":[{"label":"Molecular mass","value":"356.50 g/mol","copyable":false},{"label":"Predicted LogP","value":"6","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>23</sub>H<sub>32</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate","copyable":true},{"label":"SMILES","value":"CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C","copyable":true},{"label":"InChI","value":"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1","copyable":true},{"label":"InChIKey","value":"RSEPBGGWRJCQGY-RBRWEJTLSA-N","copyable":true},{"label":"CAS number","value":"979-32-8","copyable":true},{"label":"UNII","value":"OKG364O896","copyable":true},{"label":"PubChem CID","value":"13791","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"Oral: 12–20 hours (as estradiol), Intramuscular injection injection: 3.5 (1.2–7.2) days","copyable":false},{"label":"Duration of action","value":"Intramuscular injection injection:, • 5 mg: 7–8 days, • 10 mg: 10–14 days, • 40 mg: 2–3 weeks, • 100 mg: 3–4 weeks<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Metabolism","value":"Cleavage via esterases in the liver, blood, and tissues","copyable":false},{"label":"Excretion","value":"Urine (80%)","copyable":false},{"label":"Routes of administration","value":"By mouth, sublingual, intramuscular injection, subcutaneous injection<a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":1},"reagents":[],"atc":[],"mesh":[{"name":"Estrogens","id":"M0007795"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["induction","metabolism","inhibition"],"partners":69,"contraindicated":0},{"target":"ESR1","mechanisms":["shared target"],"partners":1,"contraindicated":0}],"mechanism":"Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.  Increases in the down-stream effects of ER binding reverses some of the symptoms of menopause, which are primarily caused by a loss of estrogenic activity.","side_effects":null,"effects":null,"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Estradiol valerate","composite":false,"routes":[{"name":"Subcutaneous","dosage":null,"onset":null,"comeup":null,"duration":null,"active":null},{"name":"Intramuscular","dosage":null,"onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":["Male to female transsexuality"],"effects":["figure changes","breast growth","body-hair reduction","skin smoothing","{xeff 'emotion intensification'}","gender-identity related {xeff 'cognitive euphoria'}","{xeff 'depression reduction'}"],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["crashes when injected weekly"]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"Other","status":"Rx-only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Estradiol_valerate"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/13791"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q5401768"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB13956"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1511"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A31561"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=979-32-8"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0303648"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D01413"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8023004"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Estradiol%20valerate"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/OKG364O896"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 13791, Estradiol valerate. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/13791>https://pubchem.ncbi.nlm.nih.gov/compound/13791</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Estradiol valerate. UNII: OKG364O896. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OKG364O896>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OKG364O896</a>","Labhart A. Clinical Endocrinology: Theory and Practice. Springer Science &amp; Business Media. 6 December 2012. <a href='https://books.google.com/books?id=DAgJCAAAQBAJ&amp;pg=PA551'>https://books.google.com/books?id=DAgJCAAAQBAJ&amp;pg=PA551</a>","Zink C. Dictionary of Obstetrics and Gynecology. Walter de Gruyter. 1 January 1988. <a href='https://books.google.com/books?id=EQlvzV9V7xIC&amp;pg=PA86'>https://books.google.com/books?id=EQlvzV9V7xIC&amp;pg=PA86</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 05:20:55","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 05:20:51","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 05:20:51","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 05:20:52","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 05:20:51","note":"hmdb.ca refused automated access to HMDB0303648"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 05:20:53","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 05:20:51","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 05:20:51","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 05:20:51","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 05:20:51","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 05:20:51","note":null}],"description":"Estradiol valerate is a estrogen, hormone, steroid substance."}